Specifically, the upregulation of mitochondrial Drp1 with concomitant downregulation of Mfn2 has been shown to promote tumourigenesis in many cancers including lung, gastric, breast, glioma, colon, ovarian, pancreatic and melanoma [72]. Here, DNM1L is linked to cancer.